Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01686568 · ClinicalTrials.gov registry record · Phase 3
Omega-3 Fatty Acids and Insulin Sensitivity
A Phase 3 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 31
- Enrollment target
NCT01686568: Completed Phase 3 study, sponsored by Mayo Clinic.
NCT01686568 is a Phase 3 study that has completed, run by Mayo Clinic. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01686568, a Phase 3 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study is being done to understand the effects of dietary omega-3 fats on insulin sensitivity in adult men and women.
Interventions
- DRUG placebo
- DRUG Omega-3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2012-12-21 |
| Est. Completion | 2015-06-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01686568
The ClinicalTrials.gov registry entry for NCT01686568 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01686568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01686568 about?
NCT01686568 is a clinical study titled "Omega-3 Fatty Acids and Insulin Sensitivity". This study is being done to understand the effects of dietary omega-3 fats on insulin sensitivity in adult men and women.
What is the current status of trial NCT01686568?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 31 participants. The study started on 2012-12-21. Estimated completion is 2015-06-08.
What interventions are being tested in trial NCT01686568?
The interventions under investigation include: placebo (DRUG), Omega-3 (DRUG).
Who is sponsoring clinical trial NCT01686568?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.